These findings are in accordance with the findings of Curiel and colleagues [7], who also demonstrated significant chemotaxis of Treg cells in response to malignant ascites in ovarian carcinoma, and inhibition of chemotaxis in vitro by anti-CCL22, but not anti-CCL17. Here, CCL17 is linked to ovarian carcinoma.